Page 4 - Christopher Posner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Intrepid Financial Planning Group LLC decreased its holdings in Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) by 20.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,500 shares of the biopharmaceutical company’s stock after selling 3,000 shares during the period. Intrepid […]

Pinnacle Associates Ltd. decreased its stake in Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) by 2.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 687,885 shares of the biopharmaceutical company’s stock after selling 17,482 shares during the quarter. Pinnacle Associates Ltd. owned approximately 1.28% […]

STAMFORD, Conn., April 10, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new...

Assenagon Asset Management S.A. raised its position in shares of Cara Therapeutics, Inc. (NASDAQ:CARA – Get Rating) by 210.5% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 101,544 shares of the biopharmaceutical company’s stock after purchasing an additional 68,844 shares during the […]

Several brokerages have updated their recommendations and price targets on shares of Cara Therapeutics (NASDAQ: CARA) in the last few weeks: 3/16/2023 – Cara Therapeutics is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 3/7/2023 – Cara Therapeutics was downgraded by analysts at Bank of America Co. from a […]